Quince Therapeutics, Inc.
QNCX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001662774
No open-market purchases or sales by Quince Therapeutics, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $4.74M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Quince Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- +2 vs. Q4 2024
- Shares held
- 5.23M
- +946.0K (+22.1%) vs. Q4 2024
- Total value
- $6.96M
- −$1.05M (−13.2%) vs. Q4 2024
- New holders
- 7
- 9 more added
- Sold out
- 5
- 9 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting QNCX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 26 | $4.74M |
| Q1 2026 | 46 | $1.44M |
| Q4 2025 | 67 | $67.5M |
| Q3 2025 | 45 | $19.2M |
| Q2 2025 | 41 | $12.5M |
| Q1 2025 | 36 | $6.96M |
| Q4 2024 | 35 | $9.55M |
| Q3 2024 | 33 | $4.04M |
| Q2 2024 | 43 | $4.68M |
| Q1 2024 | 46 | $7.71M |
| Q4 2023 | 44 | $7.83M |
| Q3 2023 | 42 | $8.40M |
| Q2 2023 | 40 | $13.5M |
| Q1 2023 | 45 | $12.0M |
| Q4 2022 | 50 | $3.44M |
| Q3 2022 | 61 | $12.4M |
| Q2 2022 | 70 | $26.0M |
| Q1 2022 | 88 | $99.5M |
| Q4 2021 | 102 | $242.8M |
| Q3 2021 | 131 | $1.76B |
| Q2 2021 | 105 | $982.9M |
| Q1 2021 | 91 | $673.5M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Quince Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,285,773 | $1.71M | 0.00% | +13,433+1.1% | Added |
| Ieq Capital, LLC | 806,780 | $1.07M | 0.01% | +806,780 | New |
| Renaissance Technologies LLC | 499,907 | $664.9K | 0.00% | −23,143−4.4% | Reduced |
| Geode Capital Management, LLC | 395,710 | $526.4K | 0.00% | +19,778+5.3% | Added |
| BlackRock, Inc. | 345,448 | $459.4K | 0.00% | −102,285−22.8% | Reduced |
| HighTower Advisors, LLC | 343,570 | $456.9K | 0.00% | +2,000+0.6% | Added |
| Alphabet Inc. | 189,122 | $251.5K | 0.02% | 00.0% | Unchanged |
| Tang Capital Management LLC | 184,383 | $245.2K | 0.01% | +184,383 | New |
| Shay Capital LLC | 184,334 | $245.2K | 0.07% | −92,465−33.4% | Reduced |
| ADAR1 Capital Management, LLC | 142,958 | $190.1K | 0.04% | 00.0% | Unchanged |
| State Street Corp | 124,911 | $166.1K | 0.00% | 00.0% | Unchanged |
| Mariner, LLC | 122,461 | $162.9K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 106,417 | $141.5K | 0.00% | +14,100+15.3% | Added |
| Scharf Investments, LLC | 91,061 | $121.1K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 77,492 | $103.1K | 0.00% | +26,968+53.4% | Added |
| Morgan Stanley | 53,574 | $71.3K | 0.00% | −23,127−30.2% | Reduced |
| Intellectus Partners, LLC | 53,312 | $70.9K | 0.02% | +53,312 | New |
| Virtu Financial LLC | 43,332 | $58.0K | 0.00% | +14,128+48.4% | Added |
| Two Sigma Investments, LP | 41,150 | $54.7K | 0.00% | +10,809+35.6% | Added |
| Citadel Advisors LLC | 40,397 | $53.7K | 0.00% | +40,397 | New |
| Gsa Capital Partners LLP | 36,627 | $49.0K | 0.00% | +36,627 | New |
| Anfield Capital Management, LLC | 30,227 | $40.2K | 0.01% | +3,571+13.4% | Added |
| HRT Financial LP | 14,613 | $19.0K | 0.00% | −5,619−27.8% | Reduced |
| Nixon Peabody Trust Co | 11,126 | $14.8K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 2,844 | $3.78K | 0.00% | −185−6.1% | Reduced |
| UBS Group AG | 706 | $939 | 0.00% | −408−36.6% | Reduced |
| JPMorgan Chase & Co | 547 | $728 | 0.00% | +2+0.4% | Added |
| JDM Financial Group LLC | 340 | $452 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 295 | $392 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 277 | $368 | 0.00% | −505−64.6% | Reduced |
| Group One Trading, L.P. | 246 | $327 | 0.00% | +246 | New |
| Hurley Capital, LLC | 121 | $161 | 0.00% | 00.0% | Unchanged |
| Westside Investment Management, Inc. | 75 | $100 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 74 | $98 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 50 | $67 | 0.00% | +50 | New |
| Barclays PLC | 23 | $30 | 0.00% | −77−77.0% | Reduced |
| Kestra Advisory Services, LLC | 0 | $0 | 0.00% | −15,359−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −10,475−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −5,165−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,697−100.0% | Sold out |
| Financial Avengers, Inc. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| EPIQ Capital Group, LLC | – | – | – | – | Not filed |